Browsing by Yonsei Author : Choi, Hye Jin

eperson profile image
Name:
Choi, Hye Jin [최혜진]
orcid http://orcid.org/0000-0001-5917-1400
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (16245321500)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 112

This table browses all dspace content
Issue DateTitleJournal Title
2023ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer CANCER RESEARCH AND TREATMENT
2023Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b studyLANCET ONCOLOGY
2023Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer - Authors' replyLANCET GASTROENTEROLOGY & HEPATOLOGY
2023Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial ECLINICALMEDICINE
2023Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14)LANCET GASTROENTEROLOGY & HEPATOLOGY
2023Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea PALLIATIVE MEDICINE REPORTS
2022Enhanced tumor targeting and timely viral release of mesenchymal stem cells/oncolytic virus complex due to GRP78 and inducible E1B55K expressions greatly increase the antitumor effect of systemic treatment MOLECULAR THERAPY-ONCOLYTICS
2022The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2022Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways BMC CANCER
2022Phase II study of gemcitabine with oxaliplatin (GEMOX) in heavily treated patients with advanced hepatocellular carcinoma after failure of sorafenib treatment (PEACH)JOURNAL OF CLINICAL ONCOLOGY
2022A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinomaJOURNAL OF CLINICAL ONCOLOGY
2021Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting RoleJOURNAL OF PROTEOME RESEARCH
2021Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade ResponsesHEPATOLOGY
2021Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations INVESTIGATIONAL NEW DRUGS
2021Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinomaJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2021Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2021Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinomaJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2021Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression BRITISH JOURNAL OF CANCER
2021Expression of Organic Anion Transporting Polypeptides in an H-Ras 12V Transgenic Mouse Model of Spontaneous Hepatocellular Carcinoma YONSEI MEDICAL JOURNAL
2021Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion CANCER RESEARCH AND TREATMENT
2021Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG) ESMO OPEN
2021Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinomaJOURNAL OF HEPATOLOGY
2021Pilot study for the Psychometric Validation of the Sheffield Profile for Assessment and Referral to Care (SPARC) in Korean Cancer Patients CANCER RESEARCH AND TREATMENT
2021Enhanced oncolytic adenoviral production by downregulation of death-domain associated protein and overexpression of precursor terminal protein SCIENTIFIC REPORTS
2020Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer careEUROPEAN JOURNAL OF CANCER CARE
2020Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas CANCER RESEARCH AND TREATMENT
2020Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With BRAF V600 Mutation-Positive MalignanciesCLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT
2020Human Organic Anion Transporting Polypeptide 1B3 Applied as an MRI-Based Reporter Gene KOREAN JOURNAL OF RADIOLOGY
2020Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer JOURNAL FOR IMMUNOTHERAPY OF CANCER
2020Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 TrialINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2020Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study CANCER SCIENCE
2020Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma SCIENTIFIC REPORTS
2019β-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers SCIENTIFIC REPORTS
2019Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric CancerONCOLOGIST
2019Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹⁸F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma YONSEI MEDICAL JOURNAL
2019Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trialANNALS OF ONCOLOGY
2019Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2019High levels of Daxx due to low cellular levels of HSP25 in murine cancer cells result in inefficient adenovirus replication EXPERIMENTAL AND MOLECULAR MEDICINE
2019Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation Cancer Medicine
2019An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma Oncologist
2019Interprofessional Collaboration Between a Multidisciplinary Palliative Care Team and the Team Pharmacist on Pain ManagementAMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE
2019Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of VaterCANCER IMMUNOLOGY IMMUNOTHERAPY
2018TGF-β downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade EXPERIMENTAL AND MOLECULAR MEDICINE
2018Multiple systemic extraneural metastasis of glioblastomaCHIRURGIA
2018Outpatient Palliative Care and Aggressiveness of End-of-Life Care in Patients with Metastatic Colorectal CancerAMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE
2017Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer CANCER RESEARCH AND TREATMENT
2017Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis. MEDICINE
2017Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib. YONSEI MEDICAL JOURNAL
2017Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation ONCOTARGET
2016Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study MEDICINE

Browse

Links